CClinicalTrials.gg
CompletedNCT05979636Updated Aug 7, 2023

Novamin on Streptococcus Mutans Count in Dental Plaque of High Caries Risk Children

An interventional study of Novamin containing toothpaste and Fluoride containing toothpaste in Dental Plaque and Dental Caries, sponsored by Hams Hamed Abdelrahman. Completed at 1 site in Egypt. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2023-08-07.

Sponsored by Hams Hamed Abdelrahman · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2022, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
3 Years to 6 Years
Sex
All
01

Study summary

Inhibition of streptococcus mutans can be effective to prevent caries in high caries-risk children. The aim of the study is to evaluate the effect of Novamin on streptococcus mutans in the plaque of high caries-risk children.

02

Conditions studied

  • Dental Plaque
  • Dental Caries
03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's enrollment of 36 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Hams Hamed Abdelrahman is the lead sponsor of 107 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Medically healthy children.
  • No erupting first permanent molars.
  • High caries risk children; Have visible cavities or have a visible plaque on their teeth.
  • Cooperative (Positive or definitely positive), according to Frankl's Behavior Rating Scale

Exclusion criteria

Exclusion Criteria:

  • History of intake of antibiotics for the past 3-4 weeks.
  • History of professional fluoride treatment over 2 weeks before the study.
  • Children with tooth structure defects.
  • Children unable to return for recall visits
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Test group

    Other: Novamin containing toothpaste

  • Active comparator
    Control group

    Other: Fluoride containing toothpaste

Interventions

  • OtherNovamin containing toothpaste

    children's teeth will be brushed using Novamin containing toothpaste.

  • OtherFluoride containing toothpaste

    children's teeth will be brushed using Fluoride containing toothpaste.

06

What researchers measure

Primary outcomes

  1. Change in bacterial count in dental plaque

    The samples will be collected from all children in the study and the level of S.mutans will be recorded.

    Time frame: 1 week, 2 weeks and 4 weeks

07

Study locations

1 site
  • Alexandria Faculty of Dentistry
    Alexandria, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05979636
Lead sponsor
Hams Hamed Abdelrahman
Responsible party
Hams Hamed Abdelrahman (Assistant lecturer of DPH and Clinical statistician, Alexandria University) — Sponsor-investigator
First posted
Aug 7, 2023
Start date
Dec 6, 2022
Primary completion
Jan 1, 2023
Completion
Jan 1, 2023
Last update
Aug 7, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion